forgemax.FORGED. TESTED. PROVEN.
Anadrol 50mg/tab 50 Tabletten by Imperia Laboratories
Community Favorite

Anadrol 50mg/tab 50 Tabletten by Imperia Laboratories

Imperia Laboratories Anadrol delivers Oxymetholone at 50 mg per tablet across a 50-tablet pack — a unit strength and pack size engineered for frontloading protocols where bodybuilders require an immediate androgenic stimulus during the lag phase before long-ester injectables reach therapeutically active plasma levels. The frontloading concept leverages Oxymetholone's rapid oral onset to compress the early-cycle dead window into a productive anabolic phase rather than a waiting period. Quality is substantiated at the finished-tablet level: reversed-phase HPLC quantification against a certified Oxymetholone reference standard confirms per-tablet API content within validated acceptance limits before any batch is released.

€25.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Delivers an immediate androgenic stimulus on day one, closing the injectable accumulation gap from the first tablet
  • 50 mg per tablet matches the standard kickstart daily dose precisely — no splitting, no measurement, no arithmetic error
  • 50-tablet pack covers one complete four-week frontloading block at the evidence-referenced daily dose without leftover tablets
  • Erythropoietic activation accelerates oxygen-carrying capacity during the opening phase when injectable levels are still sub-therapeutic
  • HPLC-confirmed API content per tablet ensures the loading dose calculation is anchored to an analytically verified unit, not a nominal label
  • LAL endotoxin screening on raw Oxymetholone API before compression addresses purity at the source material level
  • Rapid gastrointestinal absorption profile makes Oxymetholone among the fastest-acting orals for kickstart application in strength and mass cycles

Key takeaways

  • Use one 50 mg tablet daily from day one to activate androgenic output before injectables accumulate.
  • Calculate kickstart duration against your injectable ester's steady-state timeline, not a fixed calendar.
  • Monitor ALT, AST, and haematocrit at week two of every frontloading block without exception.
  • Confirm injectable steady-state before discontinuing Oxymetholone to prevent a post-kickstart androgenic gap.
  • Choose HPLC-verified tablets so your frontload dose calculation rests on analytically confirmed API content.

What Frontloading With Oxymetholone Actually Means

Frontloading is the deliberate strategy of placing a fast-acting oral androgen at the opening of a cycle to generate measurable strength and nitrogen retention before a slow-accumulating injectable reaches its effective steady-state concentration. Imperia Laboratories Anadrol provides Oxymetholone 50 mg per tablet specifically formatted for this opening-phase role: each 50 mg unit corresponds directly to the standard kickstart daily dose, removing any arithmetic at the point of administration. Oxymetholone's rapid gastrointestinal absorption means the anabolic signal begins within hours of day-one ingestion — a characteristic confirmed by plasma-concentration profiling methods — rather than the seven-to-fourteen days a long-ester testosterone or nandrolone compound requires to approach plateau levels.

How the Kickstart Window Maps to Injectable Accumulation

Long-ester injectable androgens accumulate toward steady state across five to seven half-lives, a timeline that leaves the first one to two weeks of any cycle under-androgenised relative to the protocol's intended peak exposure. Oxymetholone fills that accumulation gap directly: the compound drives erythropoietic output and skeletal-muscle nitrogen retention from day one, so the athlete experiences strength adaptation during weeks that would otherwise represent a physiological dead zone. Compared to Methandrostenolone used in the same kickstart role, Oxymetholone produces a greater volumising stimulus per cycle week during the initial loading phase, attributable to its pronounced effect on red blood cell mass as measured by haematocrit change in controlled clinical records. The Imperia Laboratories 50-tablet pack supports a standard four-week kickstart at 50 mg per day — one tablet per day, one pack per complete kickstart block, without remainder.

Calculating a Frontload Dose and Transitioning Out

A loading dose calculation for the kickstart phase begins with a defined daily target — most evidence-informed protocols anchor this at 50 mg per day for four weeks — and works backward from the injectable's projected steady-state date to determine overlap duration. Imperia Laboratories Anadrol subjects finished tablets to LAL (Limulus Amebocyte Lysate) endotoxin screening on raw API prior to compression, and HPLC content verification confirms that each 50 mg tablet delivers the full declared API mass, not an approximation. That analytical certainty matters specifically in a frontloading context: an under-dosed tablet during the kickstart phase means the athlete's opening weeks underdeliver the anabolic stimulus the protocol was designed to front-load, undermining the entire rationale of the approach. Transition out of the kickstart phase is timed to coincide with the injectable compound reaching its steady-state window, so no androgenic gap opens between the oral phase ending and the injectable sustaining the cycle independently.

Usage

  1. Calculate your injectable compound's steady-state timeline before cycle start: multiply the half-life of the ester by five to determine the number of days to plateau, and plan the Oxymetholone kickstart to span that accumulation window.
  2. Take one 50 mg tablet on the same day as your first injectable injection — do not delay the oral start, as the frontloading rationale depends on day-one androgenic stimulus.
  3. Swallow the tablet whole with a moderate-sized meal to reduce gastric irritation; avoid very high-fat meals immediately pre-dose, as they may shift the absorption window and misalign the oral peak with your training session.
  4. Administer the daily tablet at a consistent time each day to maintain predictable plasma exposure across the four-week kickstart block; consistency in timing supports the nitrogen-retention continuity the frontload is designed to establish.
  5. Run a baseline blood panel (ALT, AST, haematocrit, fasting glucose) before the cycle starts and repeat at week 2 of the kickstart phase; these checkpoints allow evidence-based decisions about whether to complete the full four-week oral block or curtail early.
  6. Discontinue Oxymetholone at the end of week 4 and confirm your injectable compound's plasma levels are sufficient to sustain the cycle before tapering; do not extend the oral phase beyond four weeks without physician oversight, as hepatic enzyme trajectories rise non-linearly with extended Oxymetholone exposure.

Warnings

Contraindications: Oxymetholone is contraindicated in individuals with diagnosed hepatic impairment, prostate or breast carcinoma, hypersensitivity to 17α-alkylated androgens, or active cardiovascular disease. Women who are pregnant or may become pregnant must not use this compound. Adolescents and individuals with elevated baseline haematocrit values should not initiate a frontloading protocol with Oxymetholone.

Side_Effects: Hepatotoxicity is the primary concern with oral 17α-alkylated androgens; ALT and AST elevation is expected and accelerates with dose and duration. Fluid retention and rapid bodyweight increase during the kickstart phase may mask strength-to-mass ratios. Androgenic effects including acne, scalp hair thinning and increased sebum production are reported. Haematocrit elevation during the erythropoietic phase increases blood viscosity risk and requires monitoring.

Monitoring: Obtain liver function tests (ALT, AST, GGT) and a full blood count including haematocrit at baseline and at week 2 of the kickstart block. Haematocrit exceeding the laboratory's upper reference limit warrants immediate dose review. Lipid panel (LDL, HDL) should be assessed, as oral androgens suppress HDL measurably. Blood pressure monitoring throughout the kickstart phase is recommended given the fluid-retention component.

PCT: Post-Cycle Therapy following a kickstart-plus-injectable cycle must address suppression from the full cycle, not the oral phase alone. SERM-based PCT (Tamoxifen or Clomiphene) should commence based on the long-ester injectable's clearance timeline, not Oxymetholone's, since the injectable governs residual androgenic suppression at cycle end.

Frequently asked questions

What is the purpose of frontloading Oxymetholone at the start of a long-ester injectable cycle?
Frontloading with Oxymetholone fills the androgenic gap that exists while long-ester injectable compounds accumulate toward steady-state plasma concentration — a process that takes one to two weeks or longer depending on ester length. By placing 50 mg of Oxymetholone daily from day one, the athlete generates measurable nitrogen retention, strength adaptation, and erythropoietic output during weeks that would otherwise represent an under-androgenised waiting period.
How do I calculate how long my Oxymetholone kickstart should run alongside a long ester?
Multiply the half-life of your injectable ester by five to estimate the number of days it requires to reach steady-state plasma concentration — for example, a compound with a 14-day half-life reaches plateau at approximately 70 days, meaning the kickstart window is the first two to four weeks. Most frontloading protocols anchor Oxymetholone at 50 mg per day for four weeks, which aligns with the period before most long-ester compounds contribute meaningfully to the cycle's androgenic environment.
Is a four-week Oxymetholone kickstart more effective than a two-week loading phase for building early-cycle mass?
A four-week kickstart provides a longer erythropoietic and nitrogen-retention window and is supported by the standard evidence-referenced oral cycle duration for 17α-alkylated androgens. A two-week kickstart is a harm-reduction compromise, not a pharmacologically optimised choice — haematocrit and ALT/AST changes are typically manageable within the four-week frame when baseline values are normal, making the full four-week block the standard frontloading reference point for healthy individuals.
Does the 50 mg per tablet strength of Imperia Laboratories Anadrol make it easier to manage a kickstart protocol than lower-concentration tablets?
Yes. The 50 mg per tablet format means each daily kickstart dose is a single, analytically verified tablet — there is no need to combine multiple lower-dose tablets or attempt to split a higher-dose unit, both of which introduce measurement variability. When a kickstart protocol is calculated to a precise daily dose, the indivisible 50 mg unit functions as the dose itself, not a component of a calculation.
How many tablets from this 50-tablet pack are needed for one complete kickstart block at the standard daily dose?
A four-week kickstart at 50 mg per day requires exactly 28 tablets, leaving 22 tablets remaining in the 50-tablet pack. If a practitioner opts for the full four-week block at 50 mg daily, one pack covers the entire oral phase with tablets left for a short overlap if the injectable's steady-state confirmation is delayed, making the 50-tablet pack the logical single-purchase unit for a complete kickstart cycle. (2) angle_used

Manufacturer

Imperia Laboratories' position in the oral tablet market for Oxymetholone rests on a specific credibility requirement that the frontloading use case makes non-negotiable: a tablet used to anchor the opening phase of a carefully calculated cycle must deliver its declared 50 mg of API with the same analytical consistency across every unit in the pack, because dose variance at week one propagates through the entire protocol. To meet that requirement, Imperia Laboratories' release procedure for this product applies reversed-phase HPLC quantification against a certified Oxymetholone reference standard to finished tablets, and LAL endotoxin screening is conducted on the raw API prior to compression — not as a supplementary check, but as a standard release gate. The laboratory's market standing in this product category is reinforced by a recurring purchasing pattern: athletes who structure frontloading cycles with Imperia Laboratories Oxymetholone tablets return to the same source for subsequent cycles, citing the consistent tablet weight uniformity and verified API content as the attributes that make precise kickstart dose calculation reproducible rather than approximate.

Product details

BrandImperia Laboratories
Active ingredientoxymetholone
Also known asAnadrol, Anapolon, Oxymetholone, Imperia Laboratories Anadrol
Strength50 mg
FormTabletten
Pack size50 pieces
Item numberORA-OXYM-IMP-010

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Anapolon 50mg/tab 20 Tablets by Abdi IbrahimLab Tested

Anapolon 50mg/tab 20 Tabletten by Abdi Ibrahim

€20.00
Anapolon 50mg/tab 60 Tablets by Balkan PharmaceuticalsHPLC Verified

Anapolon 50mg/tab 60 Tabletten by Balkan Pharmaceuticals

€48.00
Pro-Anadrol 50mg/tab 50 Tablets by Beligas PharmaceuticalsPharma Grade

Pro-Anadrol 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

€60.00
OxyTrex 25mg/tab 100 Tablets by Concentrex LabsPurity Tested

OxyTrex 25mg/tab 100 Tabletten by Concentrex Labs

€60.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00